| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1918 |
| Trial ID | NCT03579927 |
| Disease | Mantle Cell Lymphoma | Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma |
| Year | 2019 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2017-0295 |
| Cohort 1 | |||||||||
|
|||||||||